An artificial intelligence system has successfully completed a Good Manufacturing Practice (GMP) test for drug purification at a contract manufacturing organization (CMO) in Taiwan. The AI demonstrated an 11% increase in recovery rates across five experiments, indicating its potential to improve biopharmaceutical processes. This advancement was achieved through collaboration with Mycenax Biotech and GoSilico. AI
IMPACT AI's application in biopharmaceutical purification shows promise for improving recovery rates and efficiency in drug manufacturing.
RANK_REASON The cluster describes a research milestone involving an AI system applied to drug purification, which has passed a GMP test. [lever_c_demoted from research: ic=1 ai=0.7]
Read on Mastodon — sigmoid.social →
- Biopharmaceutics and Drug Disposition
- BIOS
- contract manufacturing organization
- GMP Test
- GoSilico
- Mycenax Biotech
- Taiwan
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
